Chongqing Carelife Pharmaceutical Co.,Ltd. sell "Nusinersen Sodium"
Basic Information
1.5K
111
13
4.3(8)
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Nusinersen Sodium
Details
Manufacturer(s)
Specifications
- Indication: Antisense oligonucleotide indicated for the treatment of 5q spinal muscular atrophy (SMA) by modifying SMN2 gene splicing to increase functional SMN protein.
- Dosage Form: Sterile solution for intrathecal injection, intended for the labeled route of administration.
- Storage Conditions: Store refrigerated at 2–8°C, protected from light, in the original carton; do not freeze.
- Regulatory Approval Status: Approved biological drug substance (marketed as Spinraza in multiple jurisdictions including the US FDA and EMA) supplied here as the bulk active for licensed manufacturing partners.
Documents
CEP Certificate
DMF
Other
CE
FDA
GMP
ISO
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment